Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: NEO stock price vs WAT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WAT's multiple
Needs WAT P/S.
Implied fair value · at NEO's multiple
Needs NEO P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: NEO FY 2025 (ended Dec 31, 2025) · WAT FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
NeoGenomics, Inc. · implied price per share
Bear
-$7.04
Base
-$8.29
Bull
-$9.53
Waters Corporation · implied price per share
Bear
$70.25
Base
$82.65
Bull
$95.05
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.64x
0.55x
Net debt / EBITDA
Leverage against operating earnings
-11.21x
0.76x
Cash and equivalents
Liquid reserves on the balance sheet
$159.62M
$588.77M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LABCORP HOLDINGS INC.
NEO vs LH
QUEST DIAGNOSTICS INC
NEO vs DGX
OPKO HEALTH, INC.
NEO vs OPK
Guardant Health, Inc.
NEO vs GH
Natera, Inc.
NEO vs NTRA
EXACT SCIENCES CORP
NEO vs EXAS
DANAHER CORP /DE/
NEO vs DHR
AGILENT TECHNOLOGIES, INC.
NEO vs A
BIO-RAD LABORATORIES, INC.
NEO vs BIO
THERMO FISHER SCIENTIFIC INC.
NEO vs TMO
BRUKER CORP
NEO vs BRKR
BIO-TECHNE Corp
NEO vs TECH
$538.20M
$1.41B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Price unavailable
